LHC Group (LHCG) Given Consensus Recommendation of “Buy” by Analysts

LHC Group (NASDAQ:LHCG) has been assigned an average rating of “Buy” from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $66.56.

A number of brokerages recently commented on LHCG. Zacks Investment Research downgraded LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $70.00 price target on shares of LHC Group in a research report on Wednesday, September 6th. Robert W. Baird reissued a “hold” rating and issued a $63.00 target price on shares of LHC Group in a research report on Tuesday, September 12th. BidaskClub downgraded LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Finally, Bank of America Corporation initiated coverage on LHC Group in a research report on Monday, August 21st. They issued a “buy” rating and a $76.00 target price for the company.



ILLEGAL ACTIVITY NOTICE: This story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2017/10/27/lhc-group-lhcg-given-consensus-recommendation-of-buy-by-analysts.html.

LHC Group (LHCG) traded up 0.14% during mid-day trading on Wednesday, reaching $66.34. 155,660 shares of the company’s stock traded hands. LHC Group has a 12 month low of $32.04 and a 12 month high of $73.85. The stock has a market capitalization of $1.21 billion, a PE ratio of 29.35 and a beta of 0.76. The firm’s 50-day moving average price is $66.73 and its 200 day moving average price is $62.52.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.09. The company had revenue of $260.20 million during the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. LHC Group’s revenue was up 15.1% on a year-over-year basis. During the same period last year, the business posted $0.52 earnings per share. Equities research analysts predict that LHC Group will post $2.39 EPS for the current year.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 14.80% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in LHCG. Federated Investors Inc. PA grew its position in shares of LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares in the last quarter. Acrospire Investment Management LLC grew its position in shares of LHC Group by 30.8% in the second quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after purchasing an additional 400 shares in the last quarter. Cubist Systematic Strategies LLC grew its position in shares of LHC Group by 758.0% in the second quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after purchasing an additional 1,516 shares in the last quarter. Invictus RG purchased a new position in shares of LHC Group in the first quarter valued at $125,000. Finally, US Bancorp DE grew its position in shares of LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after purchasing an additional 539 shares in the last quarter. Institutional investors own 85.93% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply